Matthew McGrew, Daniel Comas
Danaher announced Matthew McGrew will become the firm's CFO, effective Jan. 1, 2019. He will replace Daniel Comas, who will continue as an executive vice president and a member of the Office of the Chief Executive as he begins a gradual transition to retirement. McGrew joined Danaher in 2004 as director M&A Finance. He currently is Group CFO of Danaher's Diagnostics and Dental platforms. Comas has been with Danaher since 1991 and became its CFO in 2005.
Qiagen has hired Jonathan Sheldon as senior vice president in charge of the company's bioinformatics business, to fill the vacancy created when Laura Furmanski left late last year. Sheldon, who also joins Qiagen's executive committee, most recently had been in charge of health sciences at Oracle. He previously started and directed the bioinformatics group at Roche (UK) Pharmaceuticals.
Mike Harkins, Katherine Atkinson
Edico Genome has named Mike Harkins as vice president of sales and Katherine Atkinson as VP of business development. Together, they will seek to expand the global market for the DRAGEN bio IT platform, the company said. Harkins previously led bioproduction sales at Thermo Fisher Scientific, while Atkinson most recently was commercial director of global channel partners for Illumina.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.